Atıf İçin Kopyala
MBANYA J. C., AL-SIFRI S., ABDEL-RAHIM A., Satman I.
DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.109, sa.2, ss.226-232, 2015 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
109
Sayı:
2
-
Basım Tarihi:
2015
-
Doi Numarası:
10.1016/j.diabres.2015.04.030
-
Dergi Adı:
DIABETES RESEARCH AND CLINICAL PRACTICE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.226-232
-
Anahtar Kelimeler:
Ramadan, Diabetes, Gliclazide, GLUCOSE CONTROL, INSULIN SECRETAGOGUES, MUSLIM PATIENTS, DOUBLE-BLIND, SULFONYLUREA, VILDAGLIPTIN, SITAGLIPTIN, MANAGEMENT, MORTALITY, OUTCOMES
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Aim: Hypoglycemia can be a concern for patients with type 2 diabetes when fasting during Ramadan. In this analysis, we assessed the incidence of symptomatic hypoglycemic events in fasting patients treated with gliclazide or dipeptidyl peptidase-4 (DPP-4) inhibitors.